Ortin Laboratories Ltd - 539287 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S Murali Krishna MurthyDesignation :- Director Ortin Laboratories Ltd - 539287 - Amendment In The Appointed Date From 01.04.2017 To 01.04.2020 In The Scheme Of Arrangement
Amendment in the appointed date from 01.04.2017 to 01.04.2020 in the scheme of arrangement between Ortin Laboratories Limited (Demerged Company) and Vineet Laboratories Limited (Resulting Company) Ortin Laboratories Ltd - 539287 - Revised Unaudited Results For The Quarter Ended 30.09.2019
revised Unaudited results for the Quarter ended 30.09.2019 Ortin Laboratories Ltd - 539287 - Closure of Trading Window
closure of Trading window for the quarter ended 31.12.2019 Ortin Laboratories Ltd - 539287 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Ortin Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. Ortin Laboratories Ltd - 539287 - Clarification sought from Ortin Laboratories Ltd
The Exchange has sought clarification from Ortin Laboratories Ltd on 20th December, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Ortin Laboratories Ltd - 539287 - Disclosure Of Related Party Transactions For The Half Year Ended 30.09.2019 Under Regulation 23(9) Of SEBI LODR, 2015
Disclosure of Related Party Transactions for the Half year ended 30.09.2019 under regulation 23(9) of SEBI LODR, 2015 Ortin Laboratories Ltd - 539287 - Un-Audited Financial Results For Quarter And Halfyear Ended 30.09.2019
Un-audited Financial Results For Quarter and Halfyear ended 30.09.2019 Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14.11.2019
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Intimation of Board meeting to be held on 14.11.2019 Ortin Laboratories Ltd - 539287 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Reg 74(5)